HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nan-Yung Hsu Selected Research

ribonucleotide reductase M2

5/2018miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation.
10/2011Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nan-Yung Hsu Research Topics

Disease

11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2016 - 01/2002
9Neoplasms (Cancer)
05/2018 - 08/2004
6Lung Neoplasms (Lung Cancer)
12/2016 - 01/2002
3Neoplasm Metastasis (Metastasis)
12/2016 - 07/2010
3Carcinogenesis
04/2016 - 05/2002
3Infections
04/2013 - 04/2006
1Obesity
01/2018
1Weight Loss (Weight Reduction)
01/2018
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Papillomavirus Infections
04/2016
1Esophageal Squamous Cell Carcinoma
11/2014
1Esophageal Neoplasms (Esophageal Cancer)
11/2014
1Pterygium
01/2014
1Common Cold
04/2013
1Burns
04/2013
1Pharyngitis (Sore Throat)
04/2013
1Aspiration Pneumonia
04/2013
1Chills
04/2013
1Ulcer
04/2013
1Urticaria (Hives)
04/2013
1Deglutition Disorders (Dysphagia)
04/2013
1Mediastinitis
04/2013
1Fever (Fevers)
04/2013
1Airway Obstruction (Choking)
04/2013
1Adenocarcinoma
01/2009
1Stomach Neoplasms (Stomach Cancer)
02/2008
1Heroin Dependence (Heroin Abuse)
04/2006
1Hemopneumothorax
11/2005
1Esophagitis
01/2003
1Gastroesophageal Reflux (GERD)
01/2003
1Myasthenia Gravis
09/2002
1Disease Progression
05/2002

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
12/2016 - 04/2013
3Oncogene Proteins (Oncogene Protein)IBA
12/2016 - 01/2009
3Biomarkers (Surrogate Marker)IBA
11/2014 - 07/2010
3Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
11/2012 - 07/2010
2ribonucleotide reductase M2IBA
05/2018 - 10/2011
2MicroRNAs (MicroRNA)IBA
12/2016 - 01/2014
2Codon (Codons)IBA
04/2013 - 02/2008
2Indicators and Reagents (Reagents)IBA
10/2011 - 07/2010
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2018
1Messenger RNA (mRNA)IBA
12/2016
1GemcitabineFDA Link
12/2016
1ErbB Receptors (EGF Receptor)IBA
04/2016
1Benzo(a)pyreneIBA
04/2016
1CarcinogensIBA
04/2016
1DNA AdductsIBA
04/2016
1Vascular Endothelial Growth Factor CIBA
11/2014
1CortactinIBA
11/2014
1CateninsIBA
01/2014
1arginylarginine (Arg-Arg)IBA
04/2013
1Biological ProductsIBA
04/2013
1Propolis (Bee Bread)IBA
04/2013
1AntioxidantsIBA
04/2013
1DNA (Deoxyribonucleic Acid)IBA
04/2013
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
04/2013
1Focal Adhesion Protein-Tyrosine KinasesIBA
07/2007
1ElementsIBA
01/2007
1Alanine Transaminase (SGPT)IBA
08/2006
1Heroin (Diamorphine)IBA
04/2006
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2005
1Plasminogen Activators (Plasminogen Activator)IBA
04/2005
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
04/2005
1Matrix Metalloproteinases (MMPs)IBA
10/2004
1Thallium-201IBA
08/2004
1Radioisotopes (Radionuclides)IBA
01/2003
1trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (dihydrodiol dehydrogenase)IBA
05/2002
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
05/2002
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2002
1Paclitaxel (Taxol)FDA LinkGeneric
01/2002
1Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
01/2002

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2014 - 01/2002
2Therapeutics
11/2014 - 01/2002
1Bariatric Surgery
01/2018
1Traditional Medicine (Folk Remedies)
04/2013
1Tattooing
08/2006
1Aftercare (After-Treatment)
11/2005
1Conservative Treatment
11/2005
1Thymectomy
09/2002